Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma

Lambert-Eaton myasthenic syndrome (LEMS) is a rare, autoimmune or paraneoplastic condition characterized by muscle weakness and fatigability. In cancer therapy, immune checkpoint inhibitors (ICI) sensitize the immune system for tumor antigens. We report a 62-year-old, female patient with paraneoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dohrn, Maike F., Schöne, Ulrike, Küppers, Charlotte, Christen, Deborah, Schulz, Jörg B., Gess, Burkhard, Tauber, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727206/
https://www.ncbi.nlm.nih.gov/pubmed/33324947
http://dx.doi.org/10.1186/s42466-020-00099-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727206/
https://www.ncbi.nlm.nih.gov/pubmed/33324947
http://dx.doi.org/10.1186/s42466-020-00099-5

Ejemplares similares